Policy
What can governments do to support biotechnology? Measures of R&D spending and educational output are included in the Worldview Scorecard, but these efforts generally only support the foundations of a biotechnology industry—more can be done to drive commercialization. This chart shows the tax subsidy rates for large firms (blue) and small and medium enterprises (SMEs) (green). In cases where the tax subsidy rate is negative, tax incentives either do not exist, or they are lower than the negative impact of R&D investments.
SOURCE: OECD Science, Technology and Industry Scoreboard, 2009.
Corruption
< enlarge>
-
2: Intensity
Measuring a country's biotech "blood pressure" demands multiple approaches -
3: Enterprise Support
Biotechnology thrives only when a country maintains a broad collection of business resources
Worldview Scorecard
| Honduras | Saudi Arabia |
| Hungary | Switzerland |
| Ireland | Uganda |
| Italy | U.S. |
| Japan | Vietnam |
Country Spotlights
-
Brighter Days Ahead
A variety of tools—from emerging-market opportunities to mergers and acquisitions—help companies grow in a recovering market -
Harmonizing Harmonization
A better map for the global regulatory landscape
Perspectives
Advertisement
-
The Elements of Service
A Chinese CEO develops end-to-end contract research and manufacturing capabilities -
Three Biotech Game Changers
Three pioneers describe the building of biotech in India, Brazil and China.
Profiles